| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2016: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Outline of Final Research Achievements |
We investigated of expression of Liver X Receptor (LXRα/β) in normal and refractory cancer tissues of the human lung and pancreas. The result showed that LXRβ was expressed in the
various epithelial cells of normal lung and pancreas tissues. Similarly, LXRβ was expressed in the refractory cancer tissues. We next examined the efficacy of LXR targeted drug against refractory cancer cell lines, but its positive results could not be obtained.
|
